Aspirin exacerbated respiratory (AERD), also known as Samter’s Triad or aspirin-sensitive asthma, is a chronic medical condition that affects patients with asthma. Along with the common symptoms of asthma, patients with AERD also experience recurrent sinus disease with nasal polyps and sensitivity to aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs). AERD affects about 7% of all adults with asthma or about a million patients in the United States. Because each of these symptoms may be treated by different physicians, many AERD patients may remain undiagnosed for years.

Tanya M. Laidlaw, MD, Director of the AERD Program at Brigham and Women’s Hospital (BWH), explains how AERD patients are evaluated, diagnosed and desensitized to aspirin and related medications. Dr. Laidlaw also describes ongoing clinical trials at BWH evaluating new approaches to managing AERD symptoms including the use of anti-platelet medications and dietary modifications.

Learn more at

Read the Aspirin Exacerbated Respiratory Disease: Recognition and Treatment video transcript